Financial reports
ARS
2023 FY
Annual report to shareholders
11 Apr 24
10-K
2023 FY
Annual report
25 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
13 Apr 23
10-K
2022 FY
Annual report
23 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
Current reports
8-K
Other Events
1 Apr 24
8-K
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
25 Mar 24
8-K
Departure of Directors or Certain Officers
8 Mar 24
8-K
Results of Operations and Financial Condition
23 Feb 24
8-K
Other Events
22 Feb 24
8-K
Other Events
21 Dec 23
8-K
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
8 Nov 23
8-K
Regulation FD Disclosure
16 Oct 23
8-K
Entry into a Material Definitive Agreement
5 Oct 23
8-K
Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
9 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
25 Mar 24
424B5
Prospectus supplement for primary offering
23 Feb 24
424B5
Prospectus supplement for primary offering
5 Oct 23
RW
Registration withdrawal request
23 Feb 23
S-8
Registration of securities for employees
6 Jan 23
S-3
Shelf registration
6 Jan 23
425
Business combination disclosure
14 Dec 22
425
Business combination disclosure
6 Dec 22
425
Business combination disclosure
6 Dec 22
425
Business combination disclosure
14 Nov 22
Proxies
DEFA14A
Additional proxy soliciting materials
11 Apr 24
DEF 14A
Definitive proxy
11 Apr 24
PRE 14A
Preliminary proxy
1 Apr 24
DEFA14A
Additional proxy soliciting materials
13 Apr 23
DEF 14A
Definitive proxy
11 Apr 23
PRE 14A
Preliminary proxy
31 Mar 23
DEFA14A
Additional proxy soliciting materials
13 Apr 22
DEF 14A
Definitive proxy
13 Apr 22
DEFA14A
Additional proxy soliciting materials
9 Apr 21
DEF 14A
Definitive proxy
9 Apr 21
Other
EFFECT
Notice of effectiveness
19 Jan 23
CORRESP
Correspondence with SEC
13 Jan 23
UPLOAD
Letter from SEC
12 Jan 23
EFFECT
Notice of effectiveness
14 Nov 22
CORRESP
Correspondence with SEC
9 Nov 22
UPLOAD
Letter from SEC
1 Nov 22
EFFECT
Notice of effectiveness
8 Apr 20
CORRESP
Correspondence with SEC
3 Apr 20
UPLOAD
Letter from SEC
2 Apr 20
EFFECT
Notice of effectiveness
26 Nov 19